MARIANNE-open-paren-a-close-paren-_2A: MARIANNE(a), figure 2A

In raredd/kmdata: A Database of Reconstructed Individual Patient Level Data from Oncology Clinical Trials

MARIANNE(a), figure 2A

Description

Kaplan-Meier digitized data from MARIANNE(a), figure 2A (PMID 28056202). A reported sample size of 1,095 for a primary endpoint of PFS in breast cancer.

Usage

`MARIANNE(a)_2A`

Format

A data frame of 732 observations and 3 variables:

	time	event time (in months)
	event	PFS event indicator (0: no event, 1: event)
	arm	treatment arms (t-dm1, trastuzumab_taxane)

Source

Perez EA, Barrios C, Eiermann W, et al. Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study. J Clin Oncol 2017; 35: 141–8.

Examples

summary(`MARIANNE(a)_2A`)

kmplot(`MARIANNE(a)_2A`)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.